Patent ID: 8877810

Claim:
A mechanically activated amorphous gluconic acid calcium salt composition with the following ratio of ingredients, wt. %: gluconic acid calcium salt 94-97 talc 2-1 starch 2-1 calcium stearate 2-1 for treatment of dental or osseous diseases related to disorders of calcium metabolism in an organism, with a homogeneous diffuse halo in its powder X-ray diffraction diagram, expressed characteristically by shifting the centre of gravity of an absorption band of 3000-3600 cm −1 to an area of great wave numbers thru the value of no more than 200 cm −1 , presence of an absorption band with frequencies 3308 ±20, 2933±10, 1602±10, 1420±10, with an arm of 1260±40, 1085±10, 1044±10, 877±10, 682±10, 577±10 cm −1 and an additional absorption band having the frequency of 947±10 cm −1 in an IR spectrum, reducing endothermal peaks in the temperature range of 125-165° C. and increasing a peak in the temperature range of 30-100° C. with a differential thermal analysis, presence of a single intensive line with a g-factor of 2.000 to 2.006 and a width of 8 to 9 E in an electronic paramagnetic resonance spectrum, occurrence of a fine structure unresolved wide line in the regions of 60-90 ppm and 170-190 ppm in 13 C NMR spectra, shifting the resonant lines of their aqueous solutions in an area of 62.8-179.2 ppm thru the value of no more than 0.1 ppm in 13 C NMR spectra, shifting the resonant lines of their aqueous solutions in an area of 1.2-4.95 ppm thru the value of no more than 0.02 ppm in 1 H NMR spectra, increasing intensities of 160 m/z peaks of mass-spectra not less than 2.5 times and 780-1000 m/z peaks of solution extracts thereof in ethanol not less than 3 times in a mass-spectroscopic analysis.